Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

Source: Latest Political News on Fox News · Bias: Right

Summary

President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."

Related Coverage

Daily Analysis

Read the full Parallax Pulse for April 18, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From April 18, 2026

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
Latest Political News on Fox News

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

Right

President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."